HOME >> MEDICINE >> NEWS
Post-mortem brain studies reveal features of mild cognitive impairment

The brains of patients with mild cognitive impairment display pathologic features that appear to place them at an intermediate stage between normal aging and Alzheimer's disease, although some patients with mild cognitive impairment develop other types of dementia, according to two studies in the May issue of Archives of Neurology, one of the JAMA/Archives journals.

Mild cognitive impairment--difficulty with thinking, learning and memory--is increasingly recognized as a neurologic transition stage between normal cognitive function and Alzheimer's disease, according to background information in both articles. Older adults with mild cognitive impairment, especially those with a variety known as amnestic (memory-related) mild cognitive impairment, are thought to have a higher risk of progressing to clinical Alzheimer's disease. Little is known about how this condition affects the physical structures of the brain.

In the first study, Ronald C. Petersen, Ph.D., M.D., Mayo Clinic College of Medicine, Rochester, Minn., and colleagues compared the findings in autopsy tissue of brains of 15 individuals who at the time of their death had amnestic mild cognitive impairment (average age 88.9 years) to those of 28 individuals who were clinically healthy at the time of their death and 23 patients who were believed to have Alzheimer's disease at death and had undergone autopsy. The patients with mild cognitive impairment were examined every year before their death, which occurred between Sept. 1, 1986, and Dec. 31, 2004.

Most of the patients did not meet the requirements for a post-death diagnosis of Alzheimer's disease. However, the changes to their brains as compared to those of individuals without cognitive difficulties were more similar to those of patients with Alzheimer's disease. For instance, the patients had begun developing neurofibrillary tangles, or tangles in the cell bodies of neurons. The number of tangles correlated with the severity
'"/>

Contact: Lisa Lucier
507-538-0844
JAMA and Archives Journals
8-May-2006


Page: 1 2

Related medicine news :

1. Draining away brains toxic protein to stop Alzheimers
2. New research discovers independent brain networks control human walking
3. ADHD appears to be associated with depressed dopamine activity in the brain
4. First of its kind report on how children with brain tumors perform at school
5. Chemical in brain acts like a fuel gauge
6. Case study: cross-cultural bioethics training program helps fight African brain drain
7. Paying taxes, according to the brain, can bring satisfaction
8. Childrens brain responses predict impact of sleep loss on attention
9. Old memory traces in brain may trigger chronic pain
10. Stanford researchers track human stem cells transplanted into rat brain
11. Drug shows activity against brain metastases

Post Your Comments:
(Date:5/25/2015)... A recent report for Mass Live made on ... direct result of an opiate overdose in the state of ... deaths attributed to prescription opiate medications, and heroin. Mass live ... This issue doesn’t care about race. This issue doesn’t care ... state of Mass. reels from the effects of the opiate ...
(Date:5/25/2015)... 25, 2015 ProDrop Light Show allows ... neon light backdrops with a click of a mouse. Users have ... more all within Final Cut Pro X. , ProDrop Light Show ... drop zones, kaleidoscope and much more leaving infinite possibilities all within ... drop zones and text presets, users can apply their very own ...
(Date:5/25/2015)... May 25, 2015 Tunstall Americas announces ... the highest level of service to its Medical Answering ... and a restructuring of resources, Tunstall now provides a ... the Medical Answering Service to ensure superior patient satisfaction. ... it has invested over $10 million in expanded facilities ...
(Date:5/24/2015)... 2015 Pacific Prime has announced that they have ... looking at the cost of individual international health insurance. Titled: The ... at the cost of health insurance in six top expat destinations, ... Hong Kong , Singapore , ... , the UK , Article 2 presents ...
(Date:5/24/2015)... Dallas, TX (PRWEB) May 24, 2015 ... the Global and Chinese Enterokinase Industry, 2009-2019 Market Research ... as it is an exhaustive study on the present ... a special insight into the growing Chinese market of ... market and the overall status of the manufacturers in ...
Breaking Medicine News(10 mins):Health News:Opioid Deaths Increase by 33 Percent Since 2012 in Mass. 2Health News:Developers at Pixel Film Studios Release of ProDrop Light Show for Final Cut Pro X. 2Health News:Tunstall Introduces New Medical Answering Service for the 21st Century Practice 2Health News:Pacific Prime Releases 2nd Article of Cost of Health Insurance Report 2Health News:Global and Chinese Enterokinase Industry 2009-2019 Market Research Report Now Available at RnRMarketResearch.com 2Health News:Global and Chinese Enterokinase Industry 2009-2019 Market Research Report Now Available at RnRMarketResearch.com 3Health News:Global and Chinese Enterokinase Industry 2009-2019 Market Research Report Now Available at RnRMarketResearch.com 4
(Date:5/22/2015)... 2015 Research and Markets ( ... "Latest Regulations on Pharmaceutical International Multi-Center Clinical ... This is first time in history, ... international multi-center clinical trials of drugs in ... be implemented on March 1, 2015. The guidance ...
(Date:5/22/2015)... , May 22, 2015  In a sweeping analysis ... U.S., T1D Exchange researchers conclude that there ... 1 diabetes across all age groups, but especially for ... up-to-date picture of diabetes treatment, underscoring the need to ... technologies that can help type 1 patients achieve optimal ...
(Date:5/22/2015)... , May 22, 2015 AcelRx Pharmaceuticals, ... focused on the development and commercialization of innovative therapies ... announced that interim chief executive officer Howie Rosen ... and chief financial officer Tim Morris will ... of the two presentations are as follows: ...
Breaking Medicine Technology:2015 Regulations on Pharmaceutical International Multi-Center Clinical Trials in China 2Study Reveals Poor Disease Control Among Adolescents and Young Adults with Type 1 Diabetes 2Study Reveals Poor Disease Control Among Adolescents and Young Adults with Type 1 Diabetes 3Study Reveals Poor Disease Control Among Adolescents and Young Adults with Type 1 Diabetes 4Study Reveals Poor Disease Control Among Adolescents and Young Adults with Type 1 Diabetes 5AcelRx Pharmaceuticals to Present at Two Upcoming Investor Conferences In June 2
Cached News: